dc.contributor.author |
Bauer, Silke Mona |
|
dc.contributor.author |
Laufer, Stefan |
|
dc.date.accessioned |
2017-10-20T12:18:49Z |
|
dc.date.available |
2017-10-20T12:18:49Z |
|
dc.date.issued |
2017 |
|
dc.identifier.issn |
1520-4804 |
|
dc.identifier.uri |
http://hdl.handle.net/10900/78258 |
|
dc.language.iso |
en |
de_DE |
dc.publisher |
Amer Chemical Soc |
de_DE |
dc.relation.uri |
http://dx.doi.org/10.1021/acs.jmedchem.6b01647 |
de_DE |
dc.rights |
info:eu-repo/semantics/closedAccess |
|
dc.subject.ddc |
540 |
de_DE |
dc.title |
Discovery of N-{4-[5-(4-Fluorophenyl)-3-methyl-2-methylsulfanyl-3H-imidazol-4-yl]-pyridin-2-yl}-acetamide (CBS-3595), a dual p38α MAPK/PDE-4 inhibitor with activity against TNFα-related diseases |
de_DE |
dc.type |
Article |
de_DE |
utue.quellen.id |
20170815222223_00192 |
|
utue.publikation.seiten |
5290-5305 |
de_DE |
utue.personen.roh |
Albrecht, Wolfgang |
|
utue.personen.roh |
Unger, Anke |
|
utue.personen.roh |
Bauer, Silke M. |
|
utue.personen.roh |
Laufer, Stefan A. |
|
dcterms.isPartOf.ZSTitelID |
Journal of Medicinal Chemistry |
de_DE |
dcterms.isPartOf.ZS-Issue |
13 |
de_DE |
dcterms.isPartOf.ZS-Volume |
60 |
de_DE |
utue.fakultaet |
04 Medizinische Fakultät |
de_DE |